Results 131 to 140 of about 78,032 (168)

Thrombotic Thrombocytopenic Purpura Presenting as a Complex Migraine: A Case Report. [PDF]

Cureus
Thorpe DD, Patel P, Bhola K, Calfuli A, Markowski P.   +4 more
europepmc   +1 more source

Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil. [PDF]

Appl Health Econ Health Policy
Simões Correa Galendi J, Rasch H, Caramori CA, Gaiolla RD, Müller D, Nogueira VSN.   +5 more
europepmc   +1 more source

Neutrophil Aggregation in a Relapsed Case of Idiopathic Thrombocytopenic Purpura: A Case Report. [PDF]

Cureus
Aljohani M, Alfetayeh A, Alwasaidi T.
europepmc   +1 more source

Case Report: Ofatumumab treatment for concomitant multiple sclerosis and idiopathic thrombocytopenic purpura. [PDF]

Front Immunol
Yokota Y, Hara M, Nakajima H.
europepmc   +1 more source

Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States. [PDF]

J Manag Care Spec Pharm
Sullivan SD, Chaturvedi S, Gautam P, Arnaud A.   +3 more
europepmc   +1 more source

Thrombotic Thrombocytopenic Purpura in Oman: Disease Burden and Outcomes. [PDF]

Oman Med J
Al Dowaiki S, Al Hashmi K, Al-Lamki S, Al Muselhi M, Al-Khabori M.   +4 more
europepmc   +1 more source

Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura. [PDF]

Am J Hematol
Weisinger J, Bouzid R, Fadlallah J, Barbet C, Provot F, Poullin P, Neel A, Marie M, Rieu V, Kanouni T, Moranne O, Azoulay E, Marjanovic Z, Corre E, Joly AC, Baylatry MT, Joly BS, Veyradier A, Coppo P, French National Center for Thrombotic Microangiopathies (CNR‐MAT).   +19 more
europepmc   +1 more source